RAND Corporation teamed up with Pfizer Inc. to create a project called “The Teen Depression Awareness Project” in which they studied the effects of depression on teens and adults of various races, and ethnicities in an attempt to learn about the knowledge gaps in depression and develop strategies to improve depression care (RAND.) The RAND Corporation in a non profit, non-governmental “research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous.” Pfizer Inc. on the other hand is a privately owned pharmaceutical and research organization that is worldwide and dedicated to understanding, developing, and funding medical care that provides public benefit (Pfizer.) This multi-sector project focused on the academic, social and physical functioning of those affected by depression, as well as the readiness in those who acknowledged they had depression and their eagerness to get help. Also this project has shed light on the different attitudes and knowledge of different therapies across racial and ethnic groups across teens and parents alike. The main goal of the project was to seek the differences and effects of depression among various age groups, races, and ethnicities and to figure out what the next step was in breaking the barriers to treatment of depression. We believe this two-sector community could benefit from the government stepping in and creating a megacommunity by helping to fund treatment or centers for research and study on top of everything RAND and Pfizer have done. Although this study was done in the U.S. We believe if this project went internationally we could dive deeper into various cultures and races, and seek the differences across the world relating to depression and break old barriers into the world of discovery and treatment. Because of this study, we believe we can be more informed to speak to corporation, with regard to age, race and ethnicity. 

​